South Dakota Buprenorphine

Feature Your Practice at the Top of This State Page

Browse South Dakota buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Dr. Xiaolin Deng, M.D.

Physicians Plaza

201 South Lloyd Street, Suite E201

Aberdeen, SD 57401

Main Tel: (605) 622-2545

Dr. Shawna Marie Schmidt,

Avera Dakota Medical Square

815 1st Avenue, SE

Aberdeen, SD 57401

Main Tel: (605) 622-5123

Dr. Navaid Ahmed Khan, M.D.

Avera Psychiatric Associates

201 South Lloyd, Suite E-201

Aberdeen, SD 57401

Main Tel: (605) 622-2545

Dr. John E. Cook, M.D.

101 Tower Road

Suite 310

Dakota Dunes, SD 57049

Main Tel: (402) 397-1180

Dr. John E. Cook, M.D.

101 Tower Road

Suite 310

Dakota Dunes, SD 57049

Main Tel: (605) 242-3456

Julio Enrique Almeyda-Vargas, M.D.

Cheyenne River Sioux Tribe Health Center

166 Airport Road, 24276

Eagle Butte, SD 57625

Main Tel: (605) 964-6165

Dr. Clay Jospeh Pavlis, M .D.

805 West Pipestone Avenue

Flandreau, SD 57028

Main Tel: (605) 573-2000

Howard Liebowitz, M.D.

Pine Ridge IHS Hospital

Nt18

Pine Ridge, SD 57770

Main Tel: (605) 867-3006

Dr. Xiaofan Li, M.D.

Avera University Psychiatry Associates

4400 West 69th, Suite #1500

Sioux Falls, SD 57108

Main Tel: (605) 322-5700

Dr. Annette M. Bosworth, M.D.

5000 South Minnesota Avenue

Suite 100

Sioux Falls, SD 57108

Main Tel: (605) 371-6899

Dr. Jennifer Jean Tinguely, M.D.

Falls Community Health

521 North Main Avenue

Sioux Falls, SD 57104

Main Tel: (605) 367-8793

Myung J. Cho,

3934 South Western Avenue

Sioux Falls, SD 57105

Main Tel: (605) 322-7524

Marcia K. Nelson, M.D.

45125 291st Street

Viborg, SD 57070

Main Tel: (605) 760-3972

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or “Bup”, is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine.US is a national directory of approved buprenorphine physicians many of which specifically utilize Suboxone. Suboxone is presently the most popular buprenorphine-based medication prescribed around the world. Suboxone is a combination of buprenorphine and naloxone, and comes available as a thin film that is placed under the tongue once per day where it is quickly dissolved and absorbed into the bloodstream.

Buprenorphine Shown Safe and Effective in Reducing Opioid Use

A scholarly article published in The American Journal of Psychiatry found that buprenorphine was “noninferior” in elimiating opioid misuse as compared with methadone dosing. Noninferior is another way of saying reasonably similar in effectiveness.

The study was based on 272 patients meeting diagnostic criteria for Opioid Use Disorder, and was conducted over a 24 week period at 7 Canadian hospitals and community treatment clinics.

While the study did not differentiate between dependency severity levels or a patient’s years in active addiction, it did generally establish that buprenorphine was as effective in preventing opioid misuse when compared with a group of patients receiving methadone.

Progress and stabilization were primarily based on drug-testing urinalysis results although other factors were taken into consideration such as retention in opioid treatment for a longer duration of time.

Mounting evidence regarding buprenorphine safety and its overall therapeutic benefit will help to drive increases in funding for additional opioid treatment clinics and easier medication access for prospective patients desiring addiction recovery.

Opioid Use Disorder and Medication Assistance

Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy.

Buprenorphine based medications enjoy a proven track record of success in helping patients achieve long lasting stablization and elimination of their opioid withdrawal symptoms. A study recently published in the International Journal of Drug Policy found that almost 87% of those with opioid use disorder were not yet receiving therapeutic medications that could increase their likelihood of a successful recovery.

The good news is that there has been a substantial increase nationwide in the number of treatment providers who offer buprenorphine and counseling services. Organizations like BrightView and Acadia are opening clinics in multiple states and aim to expand their service availability in the year ahead.

With opioids now vulnerable to being adulterated with deadly fentanyl and other substances, it is important that people struggling with opioid use disorder (OUD) find treatment and support as soon as possible.

Buprenorphine based medications and methadone are making a real difference in restoring quality of life, and enabling patients to become once again fully productive, and able to focus on a healthy lifestyle. Medication assistance is key, and for many people opens a door that was previously closed for a very long time.